An Age-Based Framework for Evaluating Genome-Scale Sequencing Results in Newborn Screening

Documenti analoghi

• Actionability of commercial laboratory sequencing panels for newborn screening and the importance of transparency for parental decision-making
  di: DeCristo, Daniela M., et al.
  Pubblicazione: (2021)
• Parents’ perceptions of personal utility of exome sequencing results
  di: Mollison, Lonna, et al.
  Pubblicazione: (2019)
• A semiquantitative metric for evaluating clinical actionability of incidental or secondary findings from genome-scale sequencing
  di: Berg, Jonathan S., et al.
  Pubblicazione: (2016)
• Evaluating the clinical utility of early exome sequencing in diverse pediatric outpatient populations in the North Carolina Clinical Genomic Evaluation of Next-generation Exome Sequencing (NCGENES) 2 study: a randomized controlled trial
  di: Staley, Brooke S., et al.
  Pubblicazione: (2021)
• Genomic Sequencing for Newborn Screening: Results of the NC NEXUS Project
  di: Roman, Tamara S., et al.
  Pubblicazione: (2020)